KAMIE WILLIAMS: Open Payments
NPI 1689205577 · COVINGTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,444 in 104 payments from 41 companies in 2025. Trend: 2023 $2,626 · 2024 $3,784 · 2025 $2,444
Food & beverage: $2,444
| Company | Payments | Amount |
|---|---|---|
| PharmaEssentia USA Corporation | 6 | $254 |
| ABBVIE INC. | 4 | $190 |
| Janssen Biotech, Inc. | 8 | $151 |
| Novartis Pharmaceuticals Corporation | 7 | $143 |
| Celgene Corporation | 8 | $138 |
| Astellas Pharma US Inc | 5 | $125 |
| AstraZeneca Pharmaceuticals LP | 6 | $118 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $108 |
| Aveo Pharmaceuticals, Inc. | 3 | $83 |
| GlaxoSmithKline, LLC. | 3 | $74 |
Products named: BESREMI, EPKINLY, Xtandi, FOTIVDA, Lenvima, OPDIVO, REBLOZYL, TALVEY.
Industry payments across LA — which companies pay providers there.
